These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 13109114)

  • 1. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.
    DAVENPORT FM; HENNESSY AV; FRANCIS T
    J Exp Med; 1953 Dec; 98(6):641-56. PubMed ID: 13109114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1956 Jul; 104(1):85-97. PubMed ID: 13332182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza antibodies in the population of the USA; an epidemiological investigation.
    HILLEMAN MR; WERNER JH; GAULD RL
    Bull World Health Organ; 1953; 8(5-6):613-31. PubMed ID: 13094497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of influenza antibodies by serum absorption.
    JENSEN KE; DAVENPORT FM; HENNESSY AV; FRANCIS T
    J Exp Med; 1956 Aug; 104(2):199-209. PubMed ID: 13345965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variants of influenza A virus (PR8 strain). II. Serological and immunological characteristics of variants derived from variants.
    GERBER P; HAMRE D; LOOSLI CG
    J Exp Med; 1956 Apr; 103(4):413-24. PubMed ID: 13306851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to influenza.
    Schild GC; Oxford JS; Virelizier JL
    Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The viruses of the 1952-3 influenza epidemic].
    ISAACS A; DEPOUX R; FISET P
    Bull World Health Organ; 1954; 11(6):967-79. PubMed ID: 14364180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FURTHER OBSERVATIONS ON THE RELEVANCE OF SEROLOGIC RECAPITULATIONS OF HUMAN INFECTION WITH INFLUENZA VIRUSES.
    DAVENPORT FM; HENNESSY AV; DRESCHER J; MULDER J; FRANCIS T
    J Exp Med; 1964 Dec; 120(6):1087-97. PubMed ID: 14238927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.
    Andrews SF; Kaur K; Pauli NT; Huang M; Huang Y; Wilson PC
    J Virol; 2015 Mar; 89(6):3308-17. PubMed ID: 25589639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variants of influenza B virus.
    Schild GC; Pereira MS; Chakraverty P; Coleman MT; Dowdle WR; Chang WK
    Br Med J; 1973 Oct; 4(5885):127-31. PubMed ID: 4201694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.
    ARCHETTI I; HORSFALL FL
    J Exp Med; 1950 Nov; 92(5):441-62. PubMed ID: 14778924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Supplementary data on the theory concerning the cyclic evolution of influenza viruses].
    Niculescu IT; Zilişteanu E; Creţescu L; Maţepiuc M; Crainic R; Oprescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1975; 20(3):165-9. PubMed ID: 128105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antigenic composition of influenza virus measured by antibody-absorption.
    JENSEN KE; FRANCIS T
    J Exp Med; 1953 Dec; 98(6):619-39. PubMed ID: 13109113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic variants of influenza A virus, PR8 strain. I. Their development during serial passage in the lungs of partially immune mice.
    GERBER P; LOOSLI CG; HAMBRE D
    J Exp Med; 1955 Jun; 101(6):627-38. PubMed ID: 14367684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1957 Dec; 106(6):835-50. PubMed ID: 13481247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraepidemic heterogeneity of influenza A (H3N2) viruses in 1985: antigenic analysis and sensitivity to non-specific inhibitors.
    Pyhälä R; Pyhälä L; Visakorpi R
    Med Biol; 1986; 64(5):277-84. PubMed ID: 3807442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.